Heart failure in 10 years time: focus on pharmacological treatment.
McMurray
J J V
JJ
Department of Cardiology, Western Infirmary, Glasgow G11 6NT, UK. j.mcmurray@bio.gla.ac.uk
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000037:antagonists & inhibitors; D065128:Endothelin Receptor Antagonists; D005544:Forecasting; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D013565:Sympatholytics / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002317:Cardiovascular Agents; D016207:Cytokines; D065128:Endothelin Receptor Antagonists; D013565:Sympatholytics